Drew Mellan New Director of Account Management of Noble

Newly-Created Position will Focus on Representing the Customers’ Interests and Maximizing Noble’s Value by Bringing Solutions to Customer Challenges

What To Know

  • Under his guidance, GSK and Aptar Pharma partnered to launch the highly successful transition of Flonase from a prescription to an over-the-counter drug therapy, considered the “gold standard switch” by GSK and the industry.
  • In this new position, Mellan will serve as the voice of the customer, communicating their goals and interests to Noble with the purpose of maximizing value for them.

Noble, an Aptar Pharma company, announced today that Drew Mellan has joined the team as director of account management. In this new position, Mellan will serve as the voice of the customer, communicating their goals and interests to Noble with the purpose of maximizing value for them.

Drew Mellan has two decades of business development experience working with global pharmaceutical, industrial packaging, personal care and luxury fragrance companies. Most recently, he worked at Aptar Pharma, beginning in 2010 as a senior account manager where he successfully developed the company’s Consumer Health Care (CHC) business in North America. In 2015, Drew Mellan joined the Aptar GSK Global Account team. Under his guidance, GSK and Aptar Pharma partnered to launch the highly successful transition of Flonase from a prescription to an over-the-counter drug therapy, considered the “gold standard switch” by GSK and the industry.

Prior to joining Aptar Pharma, Mellan held business development management positions in the packaging industry with companies such as Sonoco Products Company, the world’s largest producer of composite cans, tubes and cores; and Qualipac America, a developer of packaging for the luxury beauty industry.

“This is a unique position for our business development team; one that places emphasis on building personal relationships to meet the needs of our existing clients and maximize our value to them,” explained Noble CEO Jeff Baker. “Drew’s overarching role is to understand and communicate our customers’ goals and interests so that Noble can leverage our expertise and best practices and identify products and core services that address their challenges.”

Drew Mellan holds a Bachelor of Science in Finance from Rowan University in New Jersey.

 

Other Executives In the News

SourceNoble
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

“Adding Michael to the Avation leadership team is our next step in launching Vivally,” said Jill Schiaparelli, founder and CEO of Avation Medical. “Patients have been crystal clear that they want a surgical-free, non-invasive treatment option for their OAB symptoms. Our focus now is to ensure that Vivally is easily accessible to the 46 million patients suffering from OAB in this country.”
Dennis has an extraordinary depth of knowledge and is highly respected in the obesity field; I could not imagine anyone more perfect to lead our company,” said Jeff Arnold, Chairman and a Director at Xeno Biosciences since 2017.
Peter Eckes offers more than a 30-year career in the agricultural industry, and provides a unique appreciation for what it takes to bring innovation to the modern agriculture marketplace at scale without losing sight of farmer and consumer needs.

By using this website you agree to accept Medical Device News Magazine Privacy Policy